Lexaria Bioscience (LEXX) Balance Sheet: Assets & Liabilities

Lexaria Bioscience (LEXX) Balance Sheet

As of Aug 31, 2025 (end of fiscal 2025), Lexaria Bioscience reported total assets of $4.18M and total liabilities of $1.57M. Shareholders' equity was $2.99M, down 61.0% from $7.66M a year earlier. Total debt stood at $109.32K against $1.97M in cash and short-term investments, a net cash position of $1.86M. That puts debt-to-equity at 0.04, compared with 0.02 a year earlier.

Lexaria Bioscience Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Lexaria Bioscience Corp. (LEXX) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Aug 2025	Aug 2024	Aug 2023	Aug 2022	Aug 2021	Aug 2020	Aug 2019	Aug 2018	Aug 2017
Current Assets
Cash and Cash Equivalents	1.80	6.50	1.35	5.81	10.92	1.29	1.29	1.73	2.53
Short-Term Investments	0.17	0.06	0.13	0.35	0.83	0.02	0.06	0.01	0.00
Cash & Short-Term Investments	1.97	6.56	1.48	6.16	11.75	1.31	1.35	1.74	2.53
Accounts Receivable	0.37	0.15	0.18	0.20	0.34	0.31	0.27	0.27	0.05
Inventory	0.00	0.00	0.00	0.04	0.03	0.12	0.13	0.09	0.07
Other Current Assets	1.33	1.19	0.55	0.58	0.32	0.18	0.07	0.19	0.15
Total Current Assets	3.47	7.90	2.20	6.98	12.44	1.93	1.82	2.28	2.80
Non-Current Assets
Property, Plant & Equipment (Net)	0.33	0.39	0.42	0.37	0.46	0.61	0.59	0.00	0.00
Intangible Assets	0.31	0.52	0.46	0.49	0.36	0.29	0.27	0.15	0.06
Other Non-Current Assets	0.06	1.03	0.00	0.86	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.71	0.97	0.88	0.86	0.82	0.90	0.86	0.15	0.06
Total Assets	4.18	8.87	3.08	7.83	13.27	2.83	2.68	2.43	2.86
Current Liabilities
Accounts Payable	1.37	1.07	0.23	0.15	0.10	0.05	0.03	0.01	0.03
Short-Term Debt	0.03	0.03	0.03	0.04	0.05	0.04	0.00	0.00	0.00
Accrued Liabilities	0.89	0.69	0.01	0.03	0.05	-	-	-	-
Deferred Revenue	0.00	0.00	0.00	0.00	0.00	0.04	0.00	0.00	0.02
Other Current Liabilities	0.10	0.00	0.00	0.00	0.00	0.10	0.09	0.03	0.04
Total Current Liabilities	1.49	1.10	0.27	0.19	0.15	0.23	0.18	0.04	0.09
Non-Current Liabilities
Long-Term Debt	0.08	0.11	0.14	0.01	0.05	0.12	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.08	0.11	0.14	0.01	0.05	0.12	0.00	0.00	0.00
Total Liabilities	1.57	1.21	0.40	0.20	0.20	0.35	0.18	0.04	0.09
Stockholders' Equity
Common Stock	0.02	0.02	0.01	0.01	0.01	0.00	0.08	0.08	0.07
Retained Earnings	-63.46	-51.56	-45.76	-39.10	-31.83	-27.80	-23.87	-19.77	-13.17
Accumulated Other Comprehensive Income	-0.07	-0.02	0.00	0.00	0.00	0.00	0.00	-0.01	0.00
Additional Paid-in Capital	66.50	59.60	48.80	47.04	45.09	30.32	26.17	22.10	16.11
Minority Interest	-0.39	-0.38	-0.36	-0.32	-0.20	-0.04	0.11	0.00	-0.24
Shares Outstanding	1.30	1.05	0.54	0.40	-	-	-	-	-
Total Stockholders' Equity	2.99	7.66	3.04	7.63	13.27	2.53	2.38	2.39	3.01
Total Liabilities & Equity	4.18	8.87	3.08	7.83	13.27	2.83	2.68	2.43	2.86

Source: Company financial statements from annual and quarterly filings. Data as of May 31, 2026. Data sources and methodology

Frequently Asked Questions About Lexaria Bioscience Balance Sheet

How much debt does Lexaria Bioscience have?

Lexaria Bioscience had total debt of $109.32K as of Aug 31, 2025, against $1.97M in cash and short-term investments. Its debt-to-equity ratio was 0.04. Total debt was $137.37K a year earlier.

What are Lexaria Bioscience's total assets?

Lexaria Bioscience reported total assets of $4.18M as of Aug 31, 2025, down 52.9% from $8.87M a year earlier. Total liabilities were $1.57M.

What is Lexaria Bioscience's shareholders' equity?

Lexaria Bioscience's shareholders' equity was $2.99M as of Aug 31, 2025, or about $2.29 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition